Advance ZincTek Ltd Market Update November 2026 Managing Director for ANO: Geoff Acton 1 Appointed March 2016 Sales and Capital Management As announced in early October, first quarter sunscreen sales were down 71%. We have witnessed a significant recoupment of sales with the end of October now down...
Chair's Presentation to Shareholders
Filed with ASX · · 12 pages · English
Summary by 6ix AI
The company plans a capital reduction and confirms that shipments to the US remain unaffected by FDA regulations. The filing also outlines forward-looking statements regarding sales recovery and future marketing strategies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Advance ZincTek Limited on 6ix
In the deck
Earlier from Advance ZincTek
- Change of Director's Interest Notice - Lev Mizikovsky
- Proposed Capital Reduction of 3 Cents
- FY26 Unaudited Profit Before Tax Up 13% on Prior Year
- Zinc Oxide 100% exempt from Pharmaceutical Tariifs
- Appendix 4D
Later from Advance ZincTek
All Advance ZincTek news releasesFollow Advance ZincTek into a list and get an email when it puts out news.
Follow Advance ZincTek